Slumping Instrument Sales Drag Thermo Fisher Revenues Down 8 Percent in Q2

According to Marijn Dekkers, president and CEO of Thermo Fisher, economic pressures continued to tamp down spending for instruments and equipment while sales of consumables increased during the second quarter. Revenues for the company's Analytical Technologies segment, which houses its mass spectrometers, dipped 14 percent year over year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.